WO2019017677A3 - 시트랄을 유효성분으로 함유하는 근력강화, 근육증강, 근육분화, 근육재생 또는 근감소증 억제효과를 갖는 조성물 - Google Patents
시트랄을 유효성분으로 함유하는 근력강화, 근육증강, 근육분화, 근육재생 또는 근감소증 억제효과를 갖는 조성물 Download PDFInfo
- Publication number
- WO2019017677A3 WO2019017677A3 PCT/KR2018/008073 KR2018008073W WO2019017677A3 WO 2019017677 A3 WO2019017677 A3 WO 2019017677A3 KR 2018008073 W KR2018008073 W KR 2018008073W WO 2019017677 A3 WO2019017677 A3 WO 2019017677A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- muscle
- citral
- differentiation
- regeneration
- strengthening
- Prior art date
Links
- 210000003205 muscle Anatomy 0.000 title abstract 13
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 title abstract 4
- 229940043350 citral Drugs 0.000 title abstract 4
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 title abstract 4
- 230000004069 differentiation Effects 0.000 title abstract 3
- 230000009756 muscle regeneration Effects 0.000 title abstract 3
- 238000005728 strengthening Methods 0.000 title abstract 3
- 239000004615 ingredient Substances 0.000 title abstract 2
- 208000001076 sarcopenia Diseases 0.000 title abstract 2
- 230000001747 exhibiting effect Effects 0.000 title 1
- 230000001629 suppression Effects 0.000 title 1
- 208000029578 Muscle disease Diseases 0.000 abstract 3
- 230000004220 muscle function Effects 0.000 abstract 3
- 102000008934 Muscle Proteins Human genes 0.000 abstract 2
- 108010074084 Muscle Proteins Proteins 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 230000002222 downregulating effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 108020004999 messenger RNA Proteins 0.000 abstract 1
- 210000000107 myocyte Anatomy 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 238000001243 protein synthesis Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000017854 proteolysis Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000014616 translation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
본 발명은 시트랄(citrale) 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 근육 질환 예방 또는 치료용, 또는 근 기능 개선용 조성물에 관한 것으로, 상기 시트랄은 근육 세포에서 근단백질 합성 및 근육량 증가와 관련된 단백질의 발현을 증가시킬 수 있고, 근 단백질 분해에 관여하는 효소의 발현은 mRNA 수준에서부터 억제할 수 있으므로 근기능 저하, 근육 소모 또는 근육 퇴화로 인한 근육 질환에 있어서 근육 분화, 근육 재생, 근육량 증가를 통해 근력 강화 효과를 나타낼 수 있으며, 근육 감소를 억제할 수 있는 바, 근육 질환 예방 또는 치료용, 근육 분화, 근육 재생 및 근육 강화 또는 근육 양(muscle mass) 증가 또는 근육 생성 촉진 또는 근 기능 개선에 이용될 수 있다.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2017-0090871 | 2017-07-18 | ||
KR1020170090871A KR101997335B1 (ko) | 2017-07-18 | 2017-07-18 | 시트랄을 유효성분으로 함유하는 근력강화, 근육증강, 근육분화, 근육재생 또는 근감소증 억제효과를 갖는 조성물 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2019017677A2 WO2019017677A2 (ko) | 2019-01-24 |
WO2019017677A3 true WO2019017677A3 (ko) | 2019-03-07 |
WO2019017677A9 WO2019017677A9 (ko) | 2019-04-11 |
Family
ID=65015182
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2018/008073 WO2019017677A2 (ko) | 2017-07-18 | 2018-07-17 | 시트랄을 유효성분으로 함유하는 근력강화, 근육증강, 근육분화, 근육재생 또는 근감소증 억제효과를 갖는 조성물 |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101997335B1 (ko) |
WO (1) | WO2019017677A2 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102080719B1 (ko) * | 2018-07-17 | 2020-02-24 | 서울대학교산학협력단 | 약콩 발효물을 포함하는 근감소증의 예방, 치료용, 근력 개선 또는 근육량 증대용 조성물 |
WO2020017915A1 (ko) * | 2018-07-19 | 2020-01-23 | 고려대학교 산학협력단 | 피톤치드를 함유하는 근감소증의 예방 또는 치료용 약학적 조성물 |
KR102666890B1 (ko) * | 2023-11-28 | 2024-05-17 | 재단법인 제주테크노파크 | 까마귀쪽나무 추출물을 함유하는 근감소증의 예방 또는 치료용 조성물 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000044467A (ja) * | 1998-07-31 | 2000-02-15 | Lion Corp | 血流促進剤 |
JP2009137916A (ja) * | 2007-12-10 | 2009-06-25 | Kirin Yakult Nextstage Co Ltd | 肥満改善用組成物 |
CN103976987A (zh) * | 2014-06-04 | 2014-08-13 | 古天津 | 一种用于治疗动脉粥状硬化的组合物 |
CN104762255A (zh) * | 2010-06-13 | 2015-07-08 | 中国科学院生物物理研究所 | 由干细胞制备心肌细胞的方法和组合物及其用途 |
WO2017065077A1 (ja) * | 2015-10-16 | 2017-04-20 | 株式会社カネカ | 筋肉増強剤 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060105055A1 (en) * | 2001-06-18 | 2006-05-18 | Michael Marenick | Arthritis and muscle soothing formulation containing whole egg powder |
KR20090044719A (ko) * | 2007-11-01 | 2009-05-07 | 바이오스펙트럼 주식회사 | 시트랄을 유효성분으로 포함하는 미백 개선용 조성물 |
KR101636946B1 (ko) * | 2013-07-29 | 2016-07-06 | 한국생명공학연구원 | 오로트산을 포함하는 근력약화 관련 질환의 예방 또는 치료용 약학적 조성물 |
KR101691123B1 (ko) * | 2014-09-26 | 2016-12-30 | 고려대학교 산학협력단 | 메티실린 저항성 균주에 대한 항균 조성물 |
CN108348565A (zh) * | 2015-05-26 | 2018-07-31 | 新树有限公司 | 一种含有桔梗提取物的用于预防和治疗肌肉疾病或改善肌肉功能的组合物 |
-
2017
- 2017-07-18 KR KR1020170090871A patent/KR101997335B1/ko active IP Right Grant
-
2018
- 2018-07-17 WO PCT/KR2018/008073 patent/WO2019017677A2/ko active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000044467A (ja) * | 1998-07-31 | 2000-02-15 | Lion Corp | 血流促進剤 |
JP2009137916A (ja) * | 2007-12-10 | 2009-06-25 | Kirin Yakult Nextstage Co Ltd | 肥満改善用組成物 |
CN104762255A (zh) * | 2010-06-13 | 2015-07-08 | 中国科学院生物物理研究所 | 由干细胞制备心肌细胞的方法和组合物及其用途 |
CN103976987A (zh) * | 2014-06-04 | 2014-08-13 | 古天津 | 一种用于治疗动脉粥状硬化的组合物 |
WO2017065077A1 (ja) * | 2015-10-16 | 2017-04-20 | 株式会社カネカ | 筋肉増強剤 |
Also Published As
Publication number | Publication date |
---|---|
WO2019017677A9 (ko) | 2019-04-11 |
KR20190009093A (ko) | 2019-01-28 |
WO2019017677A2 (ko) | 2019-01-24 |
KR101997335B1 (ko) | 2019-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2018260800B2 (en) | Hepcidin analogues and uses therof | |
WO2012072713A3 (en) | Lysine demethylase inhibitors such as cyclylcyclopropanamine derivatives for use in the treatment of diseases and disorders associated with flaviviridae | |
WO2018115097A9 (en) | Ophthalmic composition for treatment of dry eye disease | |
BR112015001847A8 (pt) | Composições e tratamento para doenças e distúrbios nos olhos | |
WO2015183963A3 (en) | Therapeutic compositions including redox-active parabenzoquinones and uses thereof | |
MX337454B (es) | Composicion acuosa que contiene bromhexina. | |
MY180626A (en) | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof | |
EA201390803A1 (ru) | Ингибиторы бромодомена и их применение | |
BR112015019794A2 (pt) | composto, composição farmacêutica, agonista do receptor de esfingosina-1-fosfato, e, uso de um composto | |
WO2019017677A3 (ko) | 시트랄을 유효성분으로 함유하는 근력강화, 근육증강, 근육분화, 근육재생 또는 근감소증 억제효과를 갖는 조성물 | |
EA201490377A1 (ru) | Лечение рассеянного склероза комбинацией лаквинимода и глатирамера ацетата | |
WO2013022846A3 (en) | Flavonoid compounds | |
BR112015015864A8 (pt) | composição farmacêutica, e, uso de uma composição farmacêutica | |
WO2017022962A8 (ko) | Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 | |
PH12017500615B1 (en) | Ophthalmic composition comprising cyclosporine and trehalose | |
WO2015099838A3 (en) | Compositions and methods of treating ocular diseases | |
MX2012012031A (es) | Inhibidores de la actividad de la proteina tirosina quinasa y uso de los mismos para tratar transtornos oftalmicos. | |
MX2019001633A (es) | Proteina derivada de la seda para el tratamiento de la inflamacion. | |
AR091724A1 (es) | Tratamiento de la esclerosis multiple con una combinacion de laquinimod y fampridina, composicion farmaceutica | |
WO2011136573A3 (ko) | 비만 치료 및 항산화 활성을 갖는 효모 가수분해물 | |
WO2014071168A3 (en) | Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients | |
WO2015195684A3 (en) | Small molecule anti-scarring agents | |
EA201791525A3 (ru) | Соединения для лечения блокады ремиелинизации при заболеваниях, связанных с экспрессией белка оболочки herv-w | |
MX2016010699A (es) | Composiciones y metodos para tratar neutropenia. | |
WO2019017676A3 (ko) | 에틸바닐린을 유효성분으로 함유하는 근력강화, 근육증강, 근육분화, 근육재생 또는 근감소증 억제효과를 갖는 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18835756 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18835756 Country of ref document: EP Kind code of ref document: A2 |